OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SMD100M56

SMD Rise PCL

Medical Equipment, Supplies & DistributionVerified

SMD Rise PCL exhibits a strong liquidity position, with a current ratio of 7.6, indicating the company can easily cover its short-term liabilities with its current assets. The company holds cash and equivalents of 230.7 million THB, which is significantly higher than its total liabilities of 179.3 million THB, further reinforcing its liquidity buffer. However, the company reported negative operating cash flow of -50.8 million THB and free cash flow of -9.9 million THB, suggesting operational inefficiencies or capital outflows. Profitability metrics are weak, with a return on equity (ROE) of -1.24% and a return on assets (ROA) of -1.03%, both below the typical thresholds for healthy performance in the healthcare equipment and services industry. The company reported a net loss of 10.5 million THB and an operating loss of 10.2 million THB, indicating a challenging operating environment. Gross profit of 43.7 million THB on total revenue of 139.3 million THB suggests margin pressures, with a gross margin of approximately 31.4%. The company's revenue is not segmented by geographic region or product line in the available data, making it difficult to assess geographic or product concentration risks. However, the lack of segment data implies a potentially undiversified revenue base, which could expose the company to regional or product-specific downturns. Looking ahead, the company's growth trajectory is uncertain, as no specific revenue growth or decline figures are provided for the current or next fiscal year. The negative operating and free cash flows suggest that the company may need to rely on external financing or asset sales to fund operations or expansion. The capital expenditure of -7.2 million THB indicates some level of investment in infrastructure or equipment, but the negative value suggests a net outflow. Risk factors for SMD Rise PCL include the company's negative net income and operating income, which could affect its ability to service debt or fund operations. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. However, the company's negative cash flows and operating losses could increase financial risk in the future if not addressed. Recent events or filings do not appear to have significantly impacted the company's financial position, as no specific events are disclosed in the available data. The company's financial statements do not indicate any recent material changes in operations or strategy.

30-day price · SMD100M(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanySMD Rise PCL
TickerSMD100M.BK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. SMD Rise PCL operates in the medical equipment, supplies, and distribution sector, providing healthcare services and equipment to the market.

Classification. SMD Rise PCL is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

SMD Rise PCL exhibits a strong liquidity position, with a current ratio of 7.6, indicating the company can easily cover its short-term liabilities with its current assets. The company holds cash and equivalents of 230.7 million THB, which is significantly higher than its total liabilities of 179.3 million THB, further reinforcing its liquidity buffer. However, the company reported negative operating cash flow of -50.8 million THB and free cash flow of -9.9 million THB, suggesting operational inefficiencies or capital outflows. Profitability metrics are weak, with a return on equity (ROE) of -1.24% and a return on assets (ROA) of -1.03%, both below the typical thresholds for healthy performance in the healthcare equipment and services industry. The company reported a net loss of 10.5 million THB and an operating loss of 10.2 million THB, indicating a challenging operating environment. Gross profit of 43.7 million THB on total revenue of 139.3 million THB suggests margin pressures, with a gross margin of approximately 31.4%. The company's revenue is not segmented by geographic region or product line in the available data, making it difficult to assess geographic or product concentration risks. However, the lack of segment data implies a potentially undiversified revenue base, which could expose the company to regional or product-specific downturns. Looking ahead, the company's growth trajectory is uncertain, as no specific revenue growth or decline figures are provided for the current or next fiscal year. The negative operating and free cash flows suggest that the company may need to rely on external financing or asset sales to fund operations or expansion. The capital expenditure of -7.2 million THB indicates some level of investment in infrastructure or equipment, but the negative value suggests a net outflow. Risk factors for SMD Rise PCL include the company's negative net income and operating income, which could affect its ability to service debt or fund operations. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. However, the company's negative cash flows and operating losses could increase financial risk in the future if not addressed. Recent events or filings do not appear to have significantly impacted the company's financial position, as no specific events are disclosed in the available data. The company's financial statements do not indicate any recent material changes in operations or strategy.
Key takeaways
  • SMD Rise PCL has a strong liquidity position with a current ratio of 7.6 and significant cash reserves.
  • The company is currently unprofitable, with a net loss of 10.5 million THB and an operating loss of 10.2 million THB.
  • Negative operating and free cash flows suggest operational inefficiencies or capital outflows.
  • The company's financial risk is currently low, but its negative cash flows and operating losses could increase risk in the future.
  • The lack of segment data implies a potentially undiversified revenue base, which could expose the company to regional or product-specific downturns.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTHB
Revenue$139.3M
Gross profit$43.7M
Operating income-$10.2M
Net income-$10.5M
R&D
SG&A
D&A
SBC
Operating cash flow-$50.8M
CapEx-$7.2M
Free cash flow-$9.9M
Total assets$1.02B
Total liabilities$179.3M
Total equity$842.8M
Cash & equivalents$230.7M
Long-term debt$50.3M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.62B$406.7M$319.7M$299.8M
FY-3$2.01B$374.9M$296.7M$146.3M
FY-2$827.3M$96.9M$79.2M-$56.6M
FY-1$793.2M$67.0M$41.7M-$126.1M
FY0$910.2M$37.4M$10.6M-$42.6M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$1.37B$895.4M$482.3M
FY-3$1.21B$1.03B$340.6M
FY-2$1.08B$900.1M$140.8M
FY-1$1.29B$759.8M$924.9k
FY0$1.40B$715.9M$1.5M
PeriodOCFCapExFCFSBC
FY-4$143.3M-$24.1M$299.8M
FY-3$466.1M-$18.3M$146.3M
FY-2$20.9M-$21.3M-$56.6M
FY-1-$30.1M-$67.1M-$126.1M
FY0-$106.5M-$47.0M-$42.6M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$139.3M-$10.2M-$10.5M-$9.9M
FQ-6$179.7M$7.1M$5.3M-$35.6M
FQ-5$252.3M$40.4M$29.1M$22.8M
FQ-4$221.9M$29.8M$17.8M-$103.0M
FQ-3$152.1M-$22.4M-$26.5M-$20.6M
FQ-2$160.9M-$11.7M-$13.8M-$81.1M
FQ-1$344.4M$42.6M$29.2M$29.6M
FQ0$252.8M$29.0M$21.6M$29.4M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$1.02B$842.8M$230.7M
FQ-6$1.08B$816.8M$220.8M
FQ-5$1.24B$845.9M$308.8M
FQ-4$1.29B$759.8M$242.7M
FQ-3$1.23B$733.3M$232.7M
FQ-2$1.20B$667.6M$90.6M
FQ-1$1.30B$696.9M$77.5M
FQ0$1.40B$715.9M$47.5M
PeriodOCFCapExFCFSBC
FQ-7-$50.8M-$7.2M-$9.9M
FQ-6-$101.1M-$25.3M-$35.6M
FQ-5-$39.2M-$40.6M$22.8M
FQ-4-$30.1M-$67.1M-$103.0M
FQ-3-$54.8M-$4.2M-$20.6M
FQ-2$161.5M-$30.6M-$81.1M
FQ-1$267.3M-$41.6M$29.6M
FQ0-$106.5M-$47.0M$29.4M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$842.8M
Net cash$180.4M
Current ratio7.6
Debt/Equity0.1
ROA-1.0%
ROE-1.2%
Cash conversion4.8%
CapEx/Revenue-5.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricSMD100MActivity
Op margin-7.3%3.9% medp25 -31.3% · p75 14.4%below median
Net margin-7.5%2.4% medp25 -30.5% · p75 11.1%below median
Gross margin31.4%46.7% medp25 28.2% · p75 63.1%below median
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-5.2%-4.8% medp25 -11.6% · p75 -2.4%below median
Debt / equity6.0%17.9% medp25 2.7% · p75 52.2%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 00:53 UTC#e240b66e
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 11:46 UTCJob: 12cb5a54